Managing residual risk in patients receiving statin therapy

Marilyn K Mann
Med J Aust 2011; 194 (1): . || doi: 10.5694/j.1326-5377.2011.tb04158.x
Published online: 3 January 2011

To the Editor: I am writing about important errors contained in a letter of reply by Hamilton-Craig.1 In his response to a letter by Montgomery,2 he states:

  • Marilyn K Mann

  • Division of Investment Management, US Securities and Exchange Commission, Washington, DC, USA.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.